Clinical Trials Browser

Phase 3 × Fallopian Tube Neoplasms × apatinib × Clear all

NCT04229615 2022-04-25

A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms